Abstract
Patients with inflammatory bowel diseases (IBD) have an excess risk of certain gastrointestinal cancers. Much work has focused on colon cancer in IBD patients, but comparatively less is known about other more rare cancers. The European Crohn's and Colitis Organization established a pathogenesis workshop to review what is known about these cancers and formulate proposals for future studies to address the most important knowledge gaps. This article reviews the current state of knowledge about small bowel adenocarcinoma, ileo-anal pouch and rectal cuff cancer, and anal/perianal fistula cancers in IBD patients.
Copyright © 2013 European Crohn's and Colitis Organisation. Published by Elsevier B.V. All rights reserved.
MeSH terms
-
Adenocarcinoma / diagnosis
-
Adenocarcinoma / epidemiology
-
Adenocarcinoma / etiology
-
Adenocarcinoma / therapy*
-
Anus Neoplasms / diagnosis
-
Anus Neoplasms / epidemiology
-
Anus Neoplasms / etiology*
-
Anus Neoplasms / therapy
-
Carcinoma / epidemiology
-
Carcinoma / etiology
-
Carcinoma / pathology
-
Colonic Pouches* / pathology
-
Congresses as Topic
-
Humans
-
Ileal Neoplasms / diagnosis
-
Ileal Neoplasms / epidemiology
-
Ileal Neoplasms / etiology
-
Ileal Neoplasms / therapy*
-
Inflammatory Bowel Diseases / complications*
-
Inflammatory Bowel Diseases / epidemiology
-
Jejunal Neoplasms / diagnosis
-
Jejunal Neoplasms / epidemiology
-
Jejunal Neoplasms / etiology
-
Jejunal Neoplasms / therapy*
-
Prognosis
-
Rectal Neoplasms / epidemiology*
-
Rectal Neoplasms / etiology
-
Rectal Neoplasms / pathology
-
Risk Factors